Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Mem. Inst. Oswaldo Cruz ; 105(4): 460-466, July 2010. tab
Article in English | LILACS | ID: lil-554813

ABSTRACT

Liver biopsy is the gold-standard method to stage fibrosis; however, it is an invasive procedure and is potentially dangerous. The main objective of this study was to evaluate biological markers, such as cytokines IL-13, IFN-ã, TNF-á and TGF-â, platelets, bilirubins (Bil), alanine aminotransferase (ALT) and aspartate aminotransferase (AST), total proteins, ã-glutamil transferase (ã-GT) and alkaline phosphatase (AP), that could be used to predict the severity of hepatic fibrosis in schistosomiasis and hepatitis C (HC) as isolated diseases or co-infections. The following patient groups were selected: HC (n = 39), HC/hepatosplenic schistosomiasis (HSS) (n = 19), HSS (n = 22) and a control group (n = 13). ANOVA and ROC curves were used for statistical analysis. P < 0.05 was considered significant. With HC patients we showed that TNF-á (p = 0.020) and AP (p = 0.005) could differentiate mild and severe fibrosis. With regard to necroinflammatory activity, AST (p = 0.002), ã-GT (p = 0.034) and AP (p = 0.001) were the best markers to differentiate mild and severe activity. In HC + HSS patients, total Bil (p = 0.008) was capable of differentiating between mild and severe fibrosis. In conclusion, our study was able to suggest biological markers that are non-invasive candidates to evaluate fibrosis and necroinflammatory activity in HC and HC + HSS.


Subject(s)
Adolescent , Adult , Aged , Humans , Middle Aged , Young Adult , Biomarkers/blood , Hepatitis C/blood , Liver Cirrhosis/blood , Liver Diseases, Parasitic/blood , Schistosomiasis/blood , Splenic Diseases/blood , Analysis of Variance , Case-Control Studies , Hepatitis C , Hepatitis C/pathology , Liver Cirrhosis , Liver Cirrhosis/pathology , Liver Diseases, Parasitic , Liver Diseases, Parasitic/pathology , Necrosis/pathology , ROC Curve , Severity of Illness Index , Schistosomiasis , Schistosomiasis/pathology , Splenic Diseases , Splenic Diseases/pathology
2.
Mem. Inst. Oswaldo Cruz ; 103(6): 561-568, Sept. 2008. ilus, tab
Article in English | LILACS | ID: lil-495731

ABSTRACT

The production and regulation of interleukin (IL) IL-13, IL-4 and interferon-gamma (IFN-³) was evaluated in 43 schistosomiasis patients with different clinical forms. Whole-blood cultures cytokine production in response to soluble egg antigen (SEA), soluble worm adult preparation (SWAP), mitogens, neutralizing antibodies or recombinant IL-13 were measured by ELISA. After SWAP stimulation, chronic patients, particularly hepatointestinals, produced higher levels of IL-4 in comparison with acute patients, suggesting the presence of a type 2 cytokine profile in these patients. Following SEA and SWAP stimulation, hepatosplenic (HS) patients showed increased levels of IFN-³ when compared with acute patients, indicating that HS disease in humans is associated with a type 1 cytokine response. The mechanisms of immune regulation are apparently different between the clinical stages of the disease, some of which are antigen-specific.


Subject(s)
Adolescent , Adult , Child , Female , Humans , Male , Middle Aged , Young Adult , Interferon-gamma/biosynthesis , /biosynthesis , /biosynthesis , Schistosomiasis mansoni/immunology , Acute Disease , Case-Control Studies , Chronic Disease , Enzyme-Linked Immunosorbent Assay , Schistosomiasis mansoni/metabolism , Young Adult
3.
Mem. Inst. Oswaldo Cruz ; 97(suppl.1): 113-114, Oct. 2002.
Article in English | LILACS | ID: lil-325010

ABSTRACT

The production and regulation of interleukin (IL) IL-13, IL-4 and interferon-gamma was evaluated in different clinical forms of human schistosomiasis. The mechanisms of immune regulation are apparently different in the various clinical stages of the disease, some of them being antigen specific


Subject(s)
Animals , Humans , Interferon-gamma , Interleukin-13 , Interleukin-4 , Schistosomiasis mansoni , Acute Disease , Antigens, Helminth , Chronic Disease , Histocompatibility Antigens Class II
SELECTION OF CITATIONS
SEARCH DETAIL